Maxheal Laboratories Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
- Paid Up Capital ₹ 2.38 Cr
- Company Age 20 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 54.02 Cr
- Satisfied Charges ₹ 13.29 Cr
- Revenue Growth 53.22%
- Profit Growth 12.36%
- Ebitda 1404.24%
- Net Worth 86.44%
- Total Assets 14.07%
About Maxheal Laboratories
Maxheal Laboratories Private Limited (MLPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 21 December 2004 and has a history of 20 years and one month. Its registered office is in Mumbai, Maharashtra.
The Corporate was formerly known as Maxheal Pharmaceuticals Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 2.38 Cr.
The company currently has active open charges totaling ₹54.02 Cr. The company has closed loans amounting to ₹13.29 Cr, as per Ministry of Corporate Affairs (MCA) records.
Mehul Sakhala, Hemlata Sakhala, and Madanlal Sakhala serve as directors at the Company.
Company Details
- Location Mumbai, Maharashtra
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24230MH2004PTC150120
-
Company No.
150120
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
21 Dec 2004
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
What products or services does Maxheal Laboratories Private Limited offer?
Maxheal Laboratories Private Limited offers a wide range of products and services, including Pharma Ingredients & Raw Materials, Anti Infective API, Antibiotic Tablets & Capsules, Flucloxacillin Capsule, Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup, Pain Relief Drugs & Pharmaceuticals, Diclofenac, Antipyretic Medication, Paracetamol Tablets.
Who are the key members and board of directors at Maxheal Laboratories?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mehul Sakhala
|
Director | 01-Apr-2006 | Current |
|
Hemlata Sakhala
|
Director | 21-Dec-2004 | Current |
|
Madanlal Sakhala
|
Director | 21-Dec-2004 | Current |
Financial Performance of Maxheal Laboratories.
Maxheal Laboratories Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 53.22% increase. The company also saw a substantial improvement in profitability, with a 12.36% increase in profit. The company's net worth Soared by an impressive increase of 86.44%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Maxheal Laboratories?
In 2022, Maxheal Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Maxheal Pharmaceuticals (India) LimitedMehul Sakhala, Hemlata Sakhala and 1 more are mutual person
Charges (Loans)
₹54.02 Cr
₹13.29 Cr
Charges Breakdown by Lending Institutions
- Others : 54.02 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 May 2023 | Others | ₹1.84 M | Open |
| 17 May 2022 | Others | ₹3.00 Cr | Open |
| 01 Dec 2021 | Others | ₹3.00 Cr | Open |
| 17 Aug 2020 | Others | ₹3.34 Cr | Open |
| 24 Sep 2019 | Others | ₹9.75 Cr | Open |
How Many Employees Work at Maxheal Laboratories?
Maxheal Laboratories has a workforce of 108 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Maxheal Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Maxheal Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.